smoking.drugabuse.gov - A Service of the National Institute on Drug Abuse - Nicotine Addiction
Nicotine addiction and other dangers of tobacco use.
Events on Smoking and Nicotine Addiction

Past Events and Summaries

  • Addicted to Nicotine: A National Research Forum
    July 27-28, 1998
    Meeting Summary

  • The Division of Epidemiology, Services and Prevention Research (DESPR) held a Scientific Meeting entitled, "Developing a Research Agenda to Improve the Impact of Tobacco Use Quit Lines" on February 23-24, 2005 at the DoubleTree Hotel & Conference Center in Rockville, Maryland. The meeting opened with presentations that gave a brief overview of Quit Lines in the United Stated and Canada. Six panels of researchers, clinicians and practitioners presented their work on: 1) Quit Lines: Integrating Clinical and Population-Based Approaches; 2) Design, Organization, and Management of Quit Line Services; 3) Accessibility, Utilization, and Promotion of Quit Line Services; 4) Quality and Outcomes of Quit Line Services; 5) Financing & Costs of Quit Line Services; and 6) Research Method Issues. Each panel was followed by a 45-minute Q&A/discussion session which produced rich information on the state of the science and future research directions.
    [Full Summary]

  • College on Problems of Drug Dependence
    (CPDD; www.cpdd.vcu.edu)
    June 2005 (Orlando, FL)
    There is currently a gap between the high prevalence of smoking problems among individuals with mental disorders and the low rate of identification and treatment by clinicians may be due to lack of evidence-based treatments and/or clinicians awareness and ability to diagnose and treat this comorbidity. The purpose of the symposium is to review the epidemiology, etiology, and management of nicotine dependence among patients with SMDs, including state-of-the-art of evidence-based smoking cessation approaches for nicotine dependent patients with comorbid psychiatric disorders such as schizophrenia, attention deficit hyperactivity disorder (ADHD), and other substance use disorders.

  • September 7, 2005
    The Neuroscience Consortium is sponsoring a Cutting Edge seminar by Julie Blendy (University of Pennsylvania). She will discuss her recent Psychopharmacology paper investigating reduced nicotine reward in obesity, and will discuss neurobiological changes, animal behavior, and human laboratory studies. Location: 3rd floor conference room, NSC

  • American Psychological Association
    (APA: http://www.apa.org/convention05/)
    August 18-20, 2005 Washington, DC
    The "Translational Research on Smoking Cessation: Types I and II" symposium showcased Type I and II translational research on the topic of smoking cessation. The first two speakers highlighted Type I translation as they present their research findings on (a) distress intolerance as a basic process that may underlie relapse during smoking cessation attempts; and (b) the use of virtual reality technology to help address physiological reactivity to cue exposure among smokers in treatment. The third and fourth speakers highlighted Type II translational research in their presentations on the (a) delivery of smoking cessation interventions in dentists' offices; and (b) design of policy-relevant smoking cessation research. Speakers included Drs. Carl Lejuez, Patrick Bordnick, Margret Walsh and Jack Hollis, with Dr. Tim Baker serving as Moderator.

  • NIH TTURC Symposium: Transdisciplinary Tobacco Use Research from the Laboratory to the Population
    Natcher Conference Center (Building 45), National Institutes of Health (Bethesda, MD)
    October 25, 2005, 3:00 P.M. to 5:00 P.M.
    Poster Session and Reception to Follow
    The Promise and Process of Transdisciplinary Research
    Robert T. Croyle, National Cancer Institute
    Preventable Risks for Nicotine Dependence: Intrauterine Environment, Socioeconomic Attainment and Gene Interactions
    Raymond Niaura, Brown University
    Applications of Carcinogen Biomarkers to Studies of Tobacco Harm Reduction
    Stephen Hecht, University of Minnesota
    Treating Tobacco Dependence: From Mouse to Man to Medicine
    Caryn Lerman, University of Pennsylvania
    Sponsored by the: National Cancer Institute * National Institute on Drug Abuse * National Institute on Alcohol Abuse and Alcoholism

  • NIDA Mini-Convention: Frontiers in Addiction
    November 11, 2005
    The mini-convention, held in conjunction with this year's Society for Neuroscience (SfN) Annual Meeting in Washington, DC will bring together an exciting group of participants from a wide array of scientific disciplines to share advances and to discuss future directions in the neuroscience of drug abuse and related areas. For registration details, please see http://www.drugabuse.gov/whatsnew/meetings/frontiers2005/.

  • National Cooperative Drug Discovery Groups for Nicotine Addiction - a NIDA Synthesis Meeting
    Wednesday February 15, 2006
    (one day prior to the 2006 SRNT meeting)
    Disney Coronado Springs Resort, Orlando FL

    This meeting will feature presentations from the currently funded NCDDG investigators on research to develop new phamacotherapies for smoking cessation. Presentations will focus on a range of research, including the design, synthesis and screening of ligands for the nicotinic cholinergic receptor and other neurochemical systems, and on-going clinical trials efforts.

    There is no fee to attend this meeting, however space is limited and pre-registration is required: http://conferences.masimax.com/srnt05/index.cfm

  • The Joint Meeting on Adolescent Treatment Effectiveness (JMATE)
    March 27-29, 2006
    Renaissance Harborplace Hotel
    202 East Pratt Street, Baltimore, MD 21202

    JMAT offers an opportunity for practice and research communities to exchange ideas and data, thereby moving the field of adolescent treatment toward increasingly effective research designs and implementation of evidence-based practice. 

    NIDA's Division of Epidemiology, Services and Prevention Research has organized a session titled "Smoking Cessation: Linking Research and Practice", scheduled for March 28th, from 9:45-11:45 am.  For more information about the JMATE conference, please see:  http://www.mayatech.com/cti/jmate/

  • NIH State-of-the-Science Conference on Tobacco: Prevention, Cessation and Control
    June 12-14, 2006
    Washington, DC

    Invited experts will present information pertinent to a series of pre-selected key questions (see URL), and a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ) will be summarized. There will be ample opportunity for conference attendees to ask questions and to comment on the presentations during open discussion periods. After weighing the scientific evidence, an unbiased, independent panel will prepare and present a State-of-the-Science statement addressing the key conference questions.

  • World Conference on Tobacco or Health
    July 12-15, 2006
    Renaissance DC Hotel
    999 9th Street
    Washington, DC 20001

    NIDA is organizing several symposia/panel discussions, including "Prenatal Nicotine Exposure: What Happens in Adolescence?" and "Nicotine Exposure During Pregnancy: How Does It Relate to Later Behavioral Problems?"

  • Society for Research on Nicotine and Tobacco
    February 21-24, 2007
    The Hilton Austin Hotel
    Austin, Texas
    www.srnt.org

    NIDA has organized a symposium entitled "A Translational Approach to Understanding Gender, Adolescence, and Vulnerability to Nicotine Addiction", chaired by Drs. Allison Chausmer and Cora Lee Wetherington.  This symposium will include presentations from animal and human research programs.  Speakers include Drs. Laura O'Dell (University of Texas at El Paso), Edward Levin (Duke University), Cheryl Oncken (University of Conn Health Center) and Eric Moolchan (NIDA IRP).

    NIDA is also participating as the NIH representative of an SRNT workshop discussing applying for jobs in academia, medical centers, and industry.

  • American Psychiatric Association
    May 19-24, 2007
    San Diego,CA
    http://www.psych.org/
    NIDA is sponsoring several symposia, including "Prenatal Nicotine Exposure: Behavioral and Brain Vulnerabilities in Development", organized by Drs. Vincent Smeriglio and Allison Chausmer. This symposium will include presentations from animal and human research programs.  Speakers include Drs. Lauren Wakschlag (University of Illinois at Chicago), Leslie Jacobsen (Yale University), Burt Sharp. (University of Tennessee Health Science Center), and Frances Leslie (University of California, Irvine).  Dr. Bennett Leventhal will serve as the discussant.

  • "Current Issues in Cigarette Smoking and HIV/AIDS" workshop
    October 9, 2007
    NIH Natcher Conference Center, Betheda, MD

    NIDA, NCI, FIC, NCMHD, and NIAID are partnering to bring together experts in the fields of smoking and HIV/AIDS research. The purpose for this workshop is to highlight understudied issues related to cigarette smoking in HIV-infected persons. In this workshop, speakers will address a wide range of topics relevant to many NIH ICs and Offices. Through breakout groups, it is anticipated that this meeting will generate a list of priority areas for future research efforts in basic research and treatment. This is an invitation-only event. Please email Allison Chausmer (achausme@nida.nih.gov) with any questions.

  • National Conference on Tobacco or Health
    October 24-26, 2007
    Minneapolis, MN

    NIDA is sponsoring two symposia at this conference.

    "New Advances in the Science of Tobacco Addiction", organized by Drs. Allison Chausmer and Cora Lee Wetheringon, will include presentations from Drs. Laura Bierut, Douglas Jorensby (University of Minnesota), Jon-Kar Zubieta (University of Michigan) and Thomas Kosten (Baylor University). This will be held on Wednesday, Oct 24 from 3:30-5:00.

    "A Translational Approach to Nicotine, Smoking and Weight", organized by Drs. Allison Chausmer and Cora Lee Wetherington, will include presentations by Drs. Andrea King (University of Chicago), Michele Levine (University of Pittsburgh), Bonnie Spring (Northwestern University) and Amy Copeland (Louisiana State University). This will be held on Thursday, October 25 from 1:30-3:00.

    www.tobaccocontrolconference.org/2007

  • Science and Future Directions for Nicotine Regulation Workshop
    Thursday, November 29-30, 2007
    Rockville, MD


  • Society for Research on Nicotine and Tobacco's 14th Annual Meeting
    February 27 - March 1, 2008
    Portland, OR
    www.srnt.org


  • "Nicotine and Neuroplasticity"
    A NIDA Neuroscience Consortium Cutting Edge Seminar

    Wednesday, May 28, 2008
    1pm - 3:15pm
    NSC conference room C

    Presenters include:
    Katumi Sumikawa, Ph.D. (University of California, Irvine)
    Daniel McGehee, Ph.D.(University of Chicago)
    Thomas Gould, Ph.D. (Temple University)


  • 2nd National Conference on Dual Diagnosis
    "Nicotine Addiction and Mental Illness: Integrating Neurobiological, Psychiatric, and Social Systems"
    June 12-13, 2008 in Indianapolis, IN
    Conference info and registration at:
    http://www.iupui.edu/~psycdept/index.php?id=96


  • "Tobacco and the Media"
    Doug Tipperman, MSW (SAMSHA)
    July 15, 2008 from 1:30-3:30
    Neuroscience Center (6001 Executive Blvd, Rockville, MD)
    NIDA 3rd floor conference room (rm 3103)

    The webcast will feature the presentations, as well as Chat features to use for questions. Two-way interaction through video and voice will not be included as a way of conserving bandwidth. This event will be webcast at: https://webmeeting.nih.gov/tobaccomedia/. No password is required.

    This event is hosted by the NIDA Nicotine/Tobacco Interest Group. Questions? Contact Allison Chausmer Hoffman (301-402-5088; HoffmanAL@nida.nih.gov)


  • "Virtual Reality and Drug Cue Reactivity"
    Wednesday July 16, 2008
    1:00 - 4:00 pm
    NSC Conference Room A1/A2

    Speakers include: Patrick Bordnick, Mark Wiederhold, and Michael Saladin. The webcast will feature the presentations, as well as Chat features to use for questions. Two-way interaction though video and voice will not be included as a way of conserving bandwidth. This event will be webcast at: https://webmeeting.nih.gov/vr/. No password is required.

    This event is hosted by the Translationally Oriented Approaches, Devices and Strategies (TOADS) Workgroup and the NIDA Nicotine/Tobacco Interest Group.

    Questions? Contact Allison Chausmer Hoffman (301-402-5088; HoffmanAL@nida.nih.gov) or Mary Kautz (301-443-3206; KautzM@nida.nih.gov)


  • "Working Group on Smoking Cessation for Hospitalized Patients with Cardiovascular Heart Disease (CHD)"
    September 17, 2008
    NHBLI with co-sponsorship by NIDA, NCI, Fogarty, OBSSR and CDC OSH. This invitation-only workshop was organized by the NIH Tobacco and Nicotine Research Interest Group (www.nih.gov/sigs/tobacco)

    Questions? Contact Allison Chausmer, Ph.D. at 301-402-5088


  • "New Directions in Smoking Cue Reactivity and Cue-Exposure Research"
    Dr. Thomas Brandon and NIDA F31 grantee Joseph Ditre (University of South Florida)
    Thursday, September 18, 2008
    Neuroscience Center (6001 Executive Blvd, Rockville, MD)
    1-2pm in 3rd floor conference room (rm 3103)

    This event is part of the Neuroscience Consortium's Cutting Edge Seminar Series. This event will be webcast. This Cutting Edge seminar will be Webcast at "https://webmeeting.nih.gov/smokingcues". The webcast will feature the presentations, as well as Chat features to use for questions. Two-way interaction through video and voice will not be included as a way of conserving bandwidth. No password is required. Please enter as a guest and use your last name and affliation as your username (e.g., AllisonHoffman@NIDA).

    This seminar is a collaborative effort between the NIDA Neuroscience Consortium and the NIDA Nicotine/Tobacco Interest Group

    Questions? Contact Allison Chausmer Hoffman (301-402-5088; HoffmanAL@nida.nih.gov)


  • Great American Smokeout
    November 20, 2008
    (Always the 3rd Thurs in November)

Smoking - It's drug addiction - Nicotine

Search NIDA's website
To find information on a particular item of interest, please use our site search below:


This searches the National Institute on Drug Abuse web site


Contact Information
For additional information please contact:
Information@
lists.nida.nih.gov


or call 301-443-1124

National Institute
on Drug Abuse

6001 Executive Blvd.
Bethesda, MD
20892-9561
USA
Link to the NIDA websiteThe National Institute on Drug Abuse, is part of the National Institutes of Health, the principal biomedical and behavioral research agency of the United States Government. NIH is a component of the U.S. Department of Health and Human Services.Link to the NIH website